Quantcast
Channel: Travis Johnson, Stock Gumshoe – Stock Gumshoe
Viewing all 2764 articles
Browse latest View live

De-teasing Gilder’s “Don’t buy 5G Stocks, Buy 15G Instead” pitch

$
0
0
Today’s ad that we’re finally covering, after tons of requests, is for Gilder’s Moonshots, which is the latest publication launched in George Gilder’s return to newsletter world. Here’s the headline from the ad: “‘Don’t invest in 5G stocks or even buy yourself a 5G smartphone… until you’ve heard about this chance to triple your gains […]

George Gilder Report

$
0
0
The entry-level newsletter from George Gilder launched in 2019, sort of a continuation of the Gilder Technology Report he published in the 1990s. Monthly newsletter promising “little-known investment opportunities that are tied to emerging technology trends.”

What’s that “First and Best Drugs” Alzheimer’s Stock for 300% gains?

$
0
0
I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]

E.B Tucker’s Strategic Trader

$
0
0
Pricier upgrade from Tucker’s Strategic Investor. Described on their website as “Casey Research’s premium trading service dedicated to finding 1,000% winners with the least amount of risk.”

“Gold Placements”, “Q-Shares” or “Omega Shares”— What’s with this “Warrants” stuff from Casey Research?

$
0
0
Today I’m throwing in a little bonus article, since it’s an interesting topic, everyone seems to be obsessed with gold again this week (though gold prices took a little tumble yesterday), and a few folks have asked about E.B. Tucker from Casey Research and his “Gold Placements” pitch. If that doesn’t sound familiar, he has […]

Friday File: How’s the Market Doing in Phase 3 Trials?

$
0
0
We’re used to seeing biotech stocks surge because of the results of a clinical trial… but it’s quite crazy to see the whole market pinning its hopes on a clinical trial. Gilead’s (GILD) Remdisivir had some weak results leak last week and that helped inspire the market selloff (“Oh no, we won’t get a drug […]

Skousen’s “Under a Buck” Potential 10-bagger in Gold

$
0
0
A quickie for you to start out this week, since gold is on the lips of many investors and I got a question about this Mark Skousen teaser. The little excerpts of the clues I got indicated that this wasn’t a heavily distributed teaser ad, it was an “upgrade” pitch to get the subscribers of […]

Researching Navellier’s “Place an informed “bet” on this 5G “Smart Antenna” technology right NOW” Teaser Pitch

$
0
0
The latest ad from Louis Navellier for his Growth Investor newsletter is a doozy… full of images of Louis Navellier driving his midlife crisis Porsche supercar around and showing off the red “turbo” button, with that serving as a “you’re too dumb to get it otherwise” metaphor for the tremendous potential of 5G wireless. We […]

Competing with Beijing’s Death Star — What’s “The Laser Defense Firm That Will Let You Retire Early”

$
0
0
Since Star Wars day just passed (May the Fourth Be With You!), I guess it’s time for a “Death Star” story — this one comes from an ad for The Wealth Warrior ($99/yr), which is Jason Simpkins’ security and defense-focused intro-level newsletter from the Outsider Club. And the headline, of course, sounds terrifying: “Beijing’s Death […]

Friday File: A Hodgepodge of Earnings

$
0
0
I’m still able to generate some enthusiasm about specific stocks that I think are appealing enough to buy at these prices… but I find it very hard to be optimistic in a macro sense right now, it really feels to me as though the market is whistling past the graveyard and being far too sanguine […]

Fry’s Investment Report

$
0
0
Entry level monthly newsletter that says it will look at “big picture trends that drive huge, multiyear moves in entire sectors” and pick stocks for that trend “at the best prices.”

Michael Fry’s “Secrets of the Richest Zip Code” Teaser Picks

$
0
0
This isn’t a brand new ad, it’s been circulating for a couple months now, but I’ve gotten a lot of questions recently and haven’t covered it before… so I’m digging in. The pitch is from Eric Fry, who launched Fry’s Investment Report as an entry-level stock-picking newsletter fairly recently (last summer, I think), and the […]

Sniffing out “The Company Leading the 18,767% Big Data Money Boom”

$
0
0
Ian King is out with another promo for his Automatic Fortunes newsletter published by Banyan Hill, and like most such “presentations” he makes some huge predictions to tantalize you with dreams of wealth. And though it sounds an awful lot like the “most important tech stock of 2019” pitch he was making last fall, I […]

Crow’s Nest teases “The #1 eSports Company to Dominate the Decade”— so what is it?

$
0
0
The latest teaser ad for The Crow’s Nest ($99) is focused on an area that I find fascinating, so I thought we’d dig into that one for you — Jimmy Mengel is pitching eSports as the next huge opportunity for investors, akin to getting in early as a team owner or investor in the NFL […]

What’s Oxford Income’s “Collect a 145% Return From ‘Infinite Energy’” Tease About?

$
0
0
My favorite kind of ads are the ones that throw in some archeology and a secret historical treasure… I guess I’m just a dime-store novel kind of guy at heart. And this week we’ve got just that from Marc Lichtenfeld, who’s peddling his Oxford Income Letter ($49, renews at $79/yr) with headlines about a secret […]

Friday File: From Weed to Shining Sea

$
0
0
Have you ever heard the quote, “nothing tastes as good as thin feels?” Such sayings have been attributed to waif model Kate Moss, plenty of her anorexic fans, and dozens of others in the perfection industry (including Stephen Covey), and I’ll confess that the sentiment has never resonated with me even a little bit (as […]

What’s Chris Wood touting as “The #1 Ten-Bagger Biotech Play for 2020?”

$
0
0
This article was originally published back in August, 2019 when we were getting lots of questions about Chris Wood’s teaser pitch — the ad is still largely the same, most of the hints and projections are identical and he still expects that February 2020 approval will send the stock soaring (yes, we’re still getting this […]

“Bypass the Coronavirus” with Cabot’s Teased “Financial Infrastructure” Stocks?

$
0
0
The latest ads from Cabot’s Global Stocks Explorer caught my eye with a “bypass the coronavirus” pitch. Here’s how the ad starts: “Bypass the Coronavirus…with this hidden gem at the heart of ‘the biggest investment boom in history’ “Operating revenue increased over 70%. “Gross profit surged 122%. “Net income was up over 60%. “Total bookings […]

Will “The Edge Eat The Cloud?” What’s being teased by IPO Insider?

$
0
0
A reader sent me a question on a topic that interest me, and he referenced a teaser pitch from Justin Spittler for his IPO Insider ($2,997/yr), so that caught my interest… His actual words were, “any chance of sleuthing these 2 edge computing companies?” … so that’s the goal today, but I’ll also try to […]

Friday File: Buys on the Edge, plus a look at Dividend Growth and Compounding

$
0
0
Sea Ltd (SE) is the stock I spent most of my time writing to you about last week, and they reported strong first quarter earnings on Monday. As expected, they saw some acceleration in users and revenue as the coronavirus began to impact Southeast Asia in March… and some indications that April represented even stronger […]
Viewing all 2764 articles
Browse latest View live


<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>